JDS Therapeutics has sold its specialty ingredient subsidiary, Nutrition21, to Everwell Health Holdings, which is backed by RoundTable Healthcare Partners. No financial terms were disclosed.
PRESS RELEASE
HARRISON, N.Y.,
JDS Therapeutics sells Nutrition21 to Everwell
JDS Therapeutics has sold its specialty ingredient subsidiary, Nutrition21, to Everwell Health Holdings, which is backed by RoundTable Healthcare Partners.
